share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

SEC announcement ·  Mar 26 19:05
Summary by Moomoo AI
John Trizzino, the Executive Vice President, Chief Commercial Officer, and Chief Business Officer (EVP, CCO, and CBO) of Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for John Trizzino is c/o Novavax, Inc., located at 700 Quince Orchard Road, Gaithersburg, MD, 20878. The transaction's impact on Trizzino's total holdings in Novavax was not included in the provided information.
John Trizzino, the Executive Vice President, Chief Commercial Officer, and Chief Business Officer (EVP, CCO, and CBO) of Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for John Trizzino is c/o Novavax, Inc., located at 700 Quince Orchard Road, Gaithersburg, MD, 20878. The transaction's impact on Trizzino's total holdings in Novavax was not included in the provided information.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more